Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Young, J. Dlugozima, P. Woodman, M. Foster, A. Connolly, V. Russell (Slough, United Kingdom). Effects of tobacco smoke and poly IC, alone and in combination, on mouse lung pathology. Eur Respir J 2013; 42: Suppl. 57, 671

Member's Comments

No comment yet.

Related content which might interest you: Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013 Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice Source: International Congress 2016 – Mechanisms of disease Year: 2016 Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 Effects of chronic cigarette smoke exposure on lung inflammation in ovalbumin-sensitized mice Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Effects of prenatal tobacco smoke exposure on pulmonary signaling networks in a murine model Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 The combination of TNF-α neutralization and dexamethasone treatment restored the corticosteroid responsiveness in tobacco smoking mice Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Efficacy of dexamethasone, roflumilast and azithromycin in a murine cigarette smoke/NTHi infection model Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 The effects of clinically relevant reference agents in a mouse model of severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Assesment of the effects of tocilizumab, adalimumab and steroid in LPS induced acute lung inflammation Source: International Congress 2016 – Airway response to infection Year: 2016 The effect of different PV extracts in the treatment of asthma in an animal model Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 A compare between two models of cigarette smoke co-exposition in ovalbumin-sensitized mice Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation Year: 2014 High fructose intake increases alveolar enlargement and muscle inflammation in mice exposed to cigarette smoke Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 The effects of intra-nasally administered anti-inflammatory compounds in a mouse model of acute COPD exacerbations Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 CHI-91040, a novel inhaled p38α inhibitor, counteracts lung inflammation induced by IL-1β in the rat Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Pharmacological profile and efficacy of GLPG1690, a novel ATX inhibitor for COPD treatment Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Ciclesonide and tiotropium synergistically inhibit airway eosinophilia in a guinea pig model of chronic asthma Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 LATE-BREAKING ABSTRACT: The involvement of serotonin in cigarette smoke-induced airway remodeling in mice Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016